Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization EBIAT Leases Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Alx Oncology Holdings (ALXO) Shares Issued (2020 - 2026)

Alx Oncology Holdings' Shares Issued history spans 4 years, with the latest figure at -$69000.0 for Q4 2023.

On a quarterly basis, Shares Issued fell 131.08% to -$69000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $384000.0, a 32.28% decrease, with the full-year FY2025 number at $24000.0, down 99.92% from a year prior.
Shares Issued hit -$69000.0 in Q4 2023 for Alx Oncology Holdings, down from $226000.0 in the prior quarter.
Over the last five years, Shares Issued for ALXO hit a ceiling of $368.0 million in Q4 2020 and a floor of -$1.8 million in Q4 2021.
Historically, Shares Issued has averaged $33.5 million across 4 years, with a median of $185000.0 in 2022.
The widest YoY moves for Shares Issued: up 4420.0% in 2023, down 131.08% in 2023.
Tracing ALXO's Shares Issued over 4 years: stood at $368.0 million in 2020, then plummeted by 100.49% to -$1.8 million in 2021, then skyrocketed by 112.2% to $222000.0 in 2022, then tumbled by 131.08% to -$69000.0 in 2023.
Business Quant data shows Shares Issued for ALXO at -$69000.0 in Q4 2023, $226000.0 in Q3 2023, and $222000.0 in Q4 2022.